| Mark C Glaum, MD, PHD | |
|
13801 Bruce B Downs Blvd, Suite 502, Tampa, FL 33613-3946 | |
| (813) 971-9743 | |
| (813) 558-9421 |
| Full Name | Mark C Glaum |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 25 Years |
| Location | 13801 Bruce B Downs Blvd, Tampa, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073598744 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | ME89482 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lockey Fox Ledford And Glaum Mds Pa | 6103819610 | 4 |
News Archive
The first malaria elimination programme was in the 1950s and 1960s. Malaria was eliminated from many countries in Asia and the Americas, largely by indoor spraying with insecticide. But the campaign had very little impact in Africa and eventually resources were moved away from malaria control.
BioSystem Development, LLC (BSD) and ProZyme, Inc. announce a partnership to redefine biotherapeutic glycan analysis workflow. The first product from this collaboration combines ProZyme's proprietary enzymatic N-deglycosylation, labeling and cleanup chemistry with BSD's AssayMAP™ high- throughput micro chromatography platform resulting in a rapid, quantitative N-glycan sample preparation method fully enabled for any scale of automation.
Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer's disease. The research, led by Giulio Maria Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of Psychiatry and Geriatrics and Adult Development at Mount Sinai School of Medicine, was published this month in Aging Cell.
Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society International Conference in Philadelphia, Pennsylvania.
› Verified 1 days ago
| Entity Name | University Medical Service Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992742324 PECOS PAC ID: 6800790221 Enrollment ID: O20031126000130 |
News Archive
The first malaria elimination programme was in the 1950s and 1960s. Malaria was eliminated from many countries in Asia and the Americas, largely by indoor spraying with insecticide. But the campaign had very little impact in Africa and eventually resources were moved away from malaria control.
BioSystem Development, LLC (BSD) and ProZyme, Inc. announce a partnership to redefine biotherapeutic glycan analysis workflow. The first product from this collaboration combines ProZyme's proprietary enzymatic N-deglycosylation, labeling and cleanup chemistry with BSD's AssayMAP™ high- throughput micro chromatography platform resulting in a rapid, quantitative N-glycan sample preparation method fully enabled for any scale of automation.
Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer's disease. The research, led by Giulio Maria Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of Psychiatry and Geriatrics and Adult Development at Mount Sinai School of Medicine, was published this month in Aging Cell.
Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society International Conference in Philadelphia, Pennsylvania.
› Verified 1 days ago
| Entity Name | Lockey Fox Ledford & Glaum Mds Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588649263 PECOS PAC ID: 6103819610 Enrollment ID: O20040408000154 |
News Archive
The first malaria elimination programme was in the 1950s and 1960s. Malaria was eliminated from many countries in Asia and the Americas, largely by indoor spraying with insecticide. But the campaign had very little impact in Africa and eventually resources were moved away from malaria control.
BioSystem Development, LLC (BSD) and ProZyme, Inc. announce a partnership to redefine biotherapeutic glycan analysis workflow. The first product from this collaboration combines ProZyme's proprietary enzymatic N-deglycosylation, labeling and cleanup chemistry with BSD's AssayMAP™ high- throughput micro chromatography platform resulting in a rapid, quantitative N-glycan sample preparation method fully enabled for any scale of automation.
Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer's disease. The research, led by Giulio Maria Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of Psychiatry and Geriatrics and Adult Development at Mount Sinai School of Medicine, was published this month in Aging Cell.
Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society International Conference in Philadelphia, Pennsylvania.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark C Glaum, MD, PHD 13801 Bruce B Downs Blvd, Suite 502, Tampa, FL 33613-3946 Ph: (813) 971-9743 | Mark C Glaum, MD, PHD 13801 Bruce B Downs Blvd, Suite 502, Tampa, FL 33613-3946 Ph: (813) 971-9743 |
News Archive
The first malaria elimination programme was in the 1950s and 1960s. Malaria was eliminated from many countries in Asia and the Americas, largely by indoor spraying with insecticide. But the campaign had very little impact in Africa and eventually resources were moved away from malaria control.
BioSystem Development, LLC (BSD) and ProZyme, Inc. announce a partnership to redefine biotherapeutic glycan analysis workflow. The first product from this collaboration combines ProZyme's proprietary enzymatic N-deglycosylation, labeling and cleanup chemistry with BSD's AssayMAP™ high- throughput micro chromatography platform resulting in a rapid, quantitative N-glycan sample preparation method fully enabled for any scale of automation.
Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer's disease. The research, led by Giulio Maria Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of Psychiatry and Geriatrics and Adult Development at Mount Sinai School of Medicine, was published this month in Aging Cell.
Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society International Conference in Philadelphia, Pennsylvania.
› Verified 1 days ago
Juan Carlos Cardet Guisasaola, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 13330 Usf Laurel Dr, Tampa, FL 33612 Phone: 813-974-2201 | |
Seong Ho Cho, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 13801 Bruce B Downs Blvd, Ste 502, Tampa, FL 33613 Phone: 813-971-9743 Fax: 813-558-9421 | |
Dr. Roberto Garcia, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10940 Sheldon Rd, Tampa, FL 33626 Phone: 813-926-4058 Fax: 813-926-9872 | |
Thomas B. Casale, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 12901 Bruce B Downs Blvd, Mdc 19, Tampa, FL 33612 Phone: 813-974-8954 | |
Dr. Shahid Iqbal, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5516 Hanley Rd, Tampa, FL 33634 Phone: 813-876-0502 Fax: 813-872-6503 | |
Mark Ballow, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2 Tampa General Cir, Stc 5th Floor, Tampa, FL 33606 Phone: 727-767-4150 Fax: 727-767-8532 |